Literature DB >> 12651122

Expression of proteins using the third domain of the Escherichia coli periplasmic-protein TolA as a fusion partner.

Gregor Anderluh1, Isa Gökçe, Jeremy H Lakey.   

Abstract

The third domain of the periplasmic protein TolA from Escherichia coli (TolAIII) was used as a fusion partner in the expression of various proteins from bacteria and eukaryotes. TolAIII is small domain, expressed in high yields as a soluble protein in the cytoplasm of E. coli. Proteins were linked to the C-terminus of TolAIII by a short flexible linker containing sites for endopeptidases. Three different vectors were prepared, containing sites for enterokinase, thrombin or factor Xa. Fusion proteins also contain a His(6)-Ser(2) tag at their N-terminus for easier purification. Up to 90 mg fusion protein per liter bacterial culture was obtained using these vectors. Colicin N R-domain was expressed with this system as a fusion and processed further for functional studies. The yield of final pure R-domain was doubled as compared to the direct expression. The system may prove to be useful in the preparation of other peptides and proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651122     DOI: 10.1016/s1046-5928(02)00681-2

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Authors:  Matija Rijavec; Maruska Budic; Peter Mrak; Manica Müller-Premru; Zdravko Podlesek; Darja Zgur-Bertok
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

2.  N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers.

Authors:  Chul Woo Kim; Kyoung Sim Han; Ki-Sun Ryu; Byung Hee Kim; Kyun-Hwan Kim; Seong Il Choi; Baik L Seong
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

3.  Immunogenicity of a Yersinia pestis vaccine antigen monomerized by circular permutation.

Authors:  David A Chalton; Julie A Musson; Helen Flick-Smith; Nicola Walker; Alistair McGregor; Heather K Lamb; E Diane Williamson; Julie Miller; John H Robinson; Jeremy H Lakey
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  Influence of Foreign DNA Introduction and Periplasmic Expression of Recombinant Human Interleukin-2 on Hydrogen Peroxide Quantity and Catalase Activity in Escherichia coli.

Authors:  Lena Mahmoudi Azar; Elnaz Mehdizadeh Aghdam; Farrokh Karimi; Babak Haghshenas; Abolfazl Barzegari; Parichehr Yaghmaei; Mohammad Saeid Hejazi
Journal:  Adv Pharm Bull       Date:  2013-08-20

5.  Controlled spatial and conformational display of immobilised bone morphogenetic protein-2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro.

Authors:  Elizabeth A Mitchell; Benjamin T Chaffey; Andrew W McCaskie; Jeremy H Lakey; Mark A Birch
Journal:  BMC Biol       Date:  2010-05-10       Impact factor: 7.431

6.  Helix orientations in membrane-associated Bcl-X(L) determined by 15N-solid-state NMR spectroscopy.

Authors:  Christopher Aisenbrey; U S Sudheendra; Helen Ridley; Philippe Bertani; Arnaud Marquette; Svetlana Nedelkina; Jeremy H Lakey; Burkhard Bechinger
Journal:  Eur Biophys J       Date:  2007-05-10       Impact factor: 1.733

7.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

8.  Global transcriptional responses to the bacteriocin colicin M in Escherichia coli.

Authors:  Simona Kamenšek; Darja Žgur-Bertok
Journal:  BMC Microbiol       Date:  2013-02-19       Impact factor: 3.605

9.  A generic expression system to produce proteins that co-assemble with alkane thiol SAM.

Authors:  Benjamin T Chaffey; Elizabeth Mitchell; Mark A Birch; Jeremy H Lakey
Journal:  Int J Nanomedicine       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.